Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience

References

• Abrams P, Andersson KE, Apostolidis A, et al. 6th International Consultation on Incontinence. Recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourol Urodyn. 2018;37(7):2271–2272.
   PubMed Web of Science ®Google Scholar
• Abrams P, Cl Wagg A, Wein A. Incontinence 6th Edition ICS; 2017. Available from: https://www.ics.org/education/icspublications/icibooks/6thicibook.
   Google Scholar
• EAU. Urinary incontinence, non-oncology guidelines: EAU; 2020. Available from: https://uroweb.org/individual-guidelines/non-oncology-guidelines/.
   Google Scholar
• AUA. Diagnosis and treatment of non-neurogenic overactive bladder (OAB) in adults: an AUA/SUFU guideline 2019; 2020. Available from: https://www.auanet.org/guidelines/overactive-bladder-(oab)-guideline.
   Google Scholar
• AUA. 2019. Available from: https://www.auanet.org/guidelines/overactive-bladder-(oab)-guideline.
   Google Scholar
• Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438–1443.
   PubMed Web of Science ®Google Scholar
• Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31(8):1206–1216.
   PubMed Web of Science ®Google Scholar
• Gobbi C, Digesu GA, Khullar V, et al. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Mult Scler. 2011;17(12):1514–1519.
   PubMed Web of Science ®Google Scholar
• Kabay SC, Kabay S, Yucel M, et al. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Neurourol Urodyn. 2009;28(1):62–67.
   PubMed Web of Science ®Google Scholar
• Tudor KI, Seth JH, Liechti MD, et al. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder. Clin Auton Res. 2020;30(1):61–67.
   PubMed Web of Science ®Google Scholar
• Canbaz Kabay S, Kabay S, Mestan E, et al. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results. Neurourol Urodyn. 2017;36(1):104–110.
   PubMed Web of Science ®Google Scholar
• Salatzki J, Liechti MD, Spanudakis E, et al. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder. BJU Int. 2019;123(5A):E20–E28.
   PubMed Web of Science ®Google Scholar
• Govier FE, Litwiller S, Nitti V, et al. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165(4):1193–1198.
   PubMed Web of Science ®Google Scholar
• Farhan B. GG. The tibal nerve (posterior tibal nerve): anatomical course and relation at the ankle. Open Acc Res in Anatomy. 2018;1:1–2.
   Google Scholar
• Sirls ER, Killinger KA, Boura JA, et al. Percutaneous tibial nerve stimulation in the office setting: real-world experience of over 100 patients. Urology. 2018;113:34–39.
   PubMed Web of Science ®Google Scholar
• Vandoninck V, van Balken MR, Finazzi AE, et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn. 2003;22(3):227–232.
   PubMed Web of Science ®Google Scholar
• de Seze M, Raibaut P, Gallien P, et al. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn. 2011;30(3):306–311.
   PubMed Web of Science ®Google Scholar
• van Balken MR, Vergunst H, Bemelmans BL. Prognostic factors for successful percutaneous tibial nerve stimulation. Eur Urol. 2006;49(2):360–365.
   PubMed Web of Science ®Google Scholar
• Iyer S, Laus K, Rugino A, et al. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder. Int Urogynecol J. 2019;30(8):1253–1259.
   PubMed Web of Science ®Google Scholar
• Kwon BE, Kim GY, Son YJ, et al. Quality of life of women with urinary incontinence: a systematic literature review. Int Neurourol J. 2010;14(3):133–138.
   PubMedGoogle Scholar
• Ko Y, Lin SJ, Salmon JW, et al. The impact of urinary incontinence on quality of life of the elderly. Am J Manag Care. 2005;11(4 Suppl):S103–S111.
   PubMed Web of Science ®Google Scholar
• Teunissen D, Van Den Bosch W, Van Weel C, et al. "It can always happen": the impact of urinary incontinence on elderly men and women. Scand J Prim Health Care. 2006;24(3):166–173.
   PubMed Web of Science ®Google Scholar
• Monz B, Chartier-Kastler E, Hampel C, et al. Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE. Eur Urol. 2007;51(4):1073–1081.
   PubMed Web of Science ®Google Scholar
• Zecca C, Panicari L, Disanto G, et al. Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis. Int Urogynecol J. 2016;27(4):521–527.
   PubMed Web of Science ®Google Scholar
• Palmer C, Nguyen N, Ghoniem G. Clinical experience with percutaneous tibial nerve stimulation in the elderly; do outcomes differ by gender? Arab J Urol. 2019;17(1):10–13.
   PubMed Web of Science ®Google Scholar
• Peters KM, Carrico DJ, Wooldridge LS, et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189(6):2194–2201.
   PubMed Web of Science ®Google Scholar
• Rostaminia G, Chang C, Pincus JB, et al. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. Int Urogynecol J. 2019;30(10):1735–1745.
   PubMed Web of Science ®Google Scholar
• Pincus J, Rostaminia G, Chang C, et al. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy. Neurourol Urodyn. 2019;38(6):1676–1684.
   PubMed Web of Science ®Google Scholar
• MacDiarmid SA, Peters KM, Shobeiri SA, et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010;183(1):234–240.
   PubMed Web of Science ®Google Scholar
• Allison SJ, Gibson W. Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience. Ther Adv Urol. 2018;10(12):411–419.
   PubMed Web of Science ®Google Scholar
• Sussman D, Yehoshua A, Kowalski J, et al. Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real-world claims data analysis. Int J Clin Pract. 2017;71(3–4):e12824.
   Web of Science ®Google Scholar
• Chapple CR, Nazir J, Hakimi Z, et al. Persistence and adherence with mirabegron versus antimuscarinic agents in patients with overactive bladder: a retrospective observational study in UK clinical practice. Eur Urol. 2017;72(3):389–399.
   PubMed Web of Science ®Google Scholar
• Bhide AA, Tailor V, Fernando R, et al. Posterior tibial nerve stimulation for overactive bladder-techniques and efficacy. Int Urogynecol J. 2020 May;31(5):865–870.
   PubMed Web of Science ®Google Scholar
• van Breda HMK, Martens FMJ, Tromp J, et al. A new implanted posterior tibial nerve stimulator for the treatment of overactive bladder syndrome: 3-month results of a novel therapy at a single center. J Urol. 2017;198(1):205–210.
   PubMed Web of Science ®Google Scholar
• Heesakkers J, Digesu GA, van Breda J, et al. A novel leadless, miniature implantable tibial nerve neuromodulation system for the management of overactive bladder complaints. Neurourol Urodyn. 2018;37(3):1060–1067.
   PubMed Web of Science ®Google Scholar
• Sherif H, Khalil M, Omar R. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation. Can J Urol. 2017;24(3):8838–8846.
   PubMed Web of Science ®Google Scholar